Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EPA/ALINT stock hub

EPA/ALINT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/ALINTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6M

Euronext Paris

Market data

Price

Recent price action with selectable time range.

EPA/ALINTEPA/ALINT

—

Loading chart…

In the news

Latest news · EPA/ALINT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-629.4

P25 n/aP50 n/aP75 n/a

ROIC-185.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/ALINT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

EUR

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	40
Employees Change	-15%
Employees Change Percent	-27.27
Enterprise value	EUR 758,497
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FR0010908723
Last refreshed	2026-05-10
Market cap	EUR 1.6M
Price	EUR 0.24
Price currency	EUR
Rev Per Employee	133,370.9x
Sector	Healthcare
Sic	2835
Symbol	epa/ALINT
Website	https://integragen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-169.77%
EV Earnings	-0.28x
EV/FCF	-0.48x
EV/Sales	0.14x
FCF yield	-100.56%
P/B ratio	-1.73x
P/S ratio	0.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-49.93%
EBITDA Margin	-49.1%
Gross margin	25.78%
Gross Profit	EUR 1.4M
Gross Profit Growth	79.06%
Gross Profit Growth3 Y	-31.82%
Gross Profit Growth5 Y	-24.06%
Net Income	EUR -2.7M
Net Income Growth Years	0%
Pretax Margin	-51.65%
Profit Margin	-49.93%
Profit Per Employee	EUR -66,596
ROA	-40.02
Roa5y	-9.7
ROCE	482.6
ROE	-629.4
Roe5y	-130.1
ROIC	-185.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-22.94%
Cagr15y	-21.63%
Cagr1y	-61.17%
Cagr3y	-42.23%
Cagr5y	-34.52%
EPS Growth Years	0
Revenue Growth	-38.67x
Revenue Growth Q	-40.2x
Revenue Growth Years	0x
Revenue Growth3 Y	-21.62x
Revenue Growth5 Y	-15.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.28
Assets	EUR 2.8M
Cash	EUR 1.1M
Current Assets	EUR 3.4M
Current Liabilities	EUR 2.8M
Debt	EUR 304,597
Debt FCF	EUR -0.19
Equity	EUR -908,525
Interest Coverage	-1,426.1
Liabilities	EUR 3.7M
Long Term Assets	EUR -581,649
Long Term Liabilities	EUR 875,876
Net Cash	EUR 810,605
Net Cash By Market Cap	EUR 51.66
Net Cash Growth	25.58%
Tangible Book Value	EUR -908,525
WACC	5.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.79
Inventory Turnover	23.72
Net Working Capital	EUR -1.5M
Quick ratio	0.71
Working Capital	EUR -705,688
Working Capital Turnover	EUR 4.08

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-92.62%
1Y total return	-61.14%
200-day SMA	0.18
3Y total return	-80.73%
50-day SMA	0.18
50-day SMA vs 200-day SMA	50under200
5Y total return	-87.96%
All Time High	11.98
All Time High Change	-98.02%
All Time High Date	2011-03-03
All Time Low	0.12
All Time Low Change	106.09%
All Time Low Date	2025-11-10
ATR	0.02
Beta	0.33
Beta1y	-0.14
Beta2y	0.11
Ch YTD	78.2
High	0.24
High52	0.73
High52 Date	2025-05-21
High52ch	-67.62%
Low	0.18
Low52	0.12
Low52 Date	2025-11-10
Low52ch	106.09%
Ma50ch	34.43%
Price vs 200-day SMA	28.94%
RSI	72.42
RSI Monthly	36.24
RSI Weekly	58.24
Sharpe ratio	-0.4x
Sortino ratio	-0.52
Tr YTD	78.2
Tr15y	-97.42%
Tr1m	24.74%
Tr1w	40.24%
Tr3m	61.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -2.7M
Operating margin	-49.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	748,713
Shares Out	6,620,708

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -1.6M
Average Volume	9,918.95x
CAPEX	EUR -2,266
Ch10y	-92.62
Ch15y	-97.42
Ch1m	24.74
Ch1w	40.24
Ch1y	-61.14
Ch3m	61.22
Ch3y	-80.73
Ch5y	-87.96
Ch6m	75.56
Change	38.6%
Change From Open	33.9
Close	0.17
Days Gap	3.51
Depreciation Amortization	44,703
Dollar Volume	26,405.1
Earnings Date	2026-09-17
EBIT	EUR -2.7M
EBITDA	EUR -2.6M
F Score	2
FCF	EUR -1.6M
FCF EV Yield	-208.03x
FCF Per Share	EUR -0.24
Financing CF	748,713
Fiscal Year End	December
Founded	2,000
Income Tax	EUR -91,787
Investing CF	40,245
Is Primary Listing	1
Last Earnings Date	2025-09-17
Last Report Date	2025-06-30
Ma150	0.16
Ma150ch	49.72%
Ma20	0.17
Ma20ch	35.51%
Net CF	-786,662
Next Earnings Date	2026-09-17
Open	0.18
Position In Range	100
Ppne	88,000
Price Date	2026-05-08
Relative Volume	25.1x
Revenue	5,334,836x
Tax By Revenue	-1.72x
Tr6m	75.56%
Volume	111,414

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EPA/ALINT pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/ALINT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

EPA/ALINT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

72.4

Above 70: short-term overbought

Price vs 200-day MA

+28.9%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

-0.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/ALINT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/ALINT stock rating?

epa/ALINT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/ALINT analysis?

The full report lives at /stocks/epa/ALINT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/ALINT?

The latest report frames epa/ALINT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/ALINT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.